The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gut microbiota-associated compounds increase lethal prostate cancer risk.
 
Bryan Douglas Naelitz
No Relationships to Disclose
 
Chad A. Reichard
No Relationships to Disclose
 
Zeneng Wang
Patents, Royalties, Other Intellectual Property - Cleveland HeartLab
 
Xun Jia
No Relationships to Disclose
 
Jianbo Li
No Relationships to Disclose
 
Meir J. Stampfer
Stock and Other Ownership Interests - Elysium
Consulting or Advisory Role - Elysium
 
Eric A. Klein
Consulting or Advisory Role - Cellanyx Diagnostics; GRAIL
 
Stanley L. Hazen
Consulting or Advisory Role - Procter & Gamble
Research Funding - Procter & Gamble; Roche
Patents, Royalties, Other Intellectual Property - Cleveland HeartLab
 
Nima Sharifi
Consulting or Advisory Role - Celgene
Research Funding - Janssen Oncology
Patents, Royalties, Other Intellectual Property - A patent application has been filed by Cleveland Clinic for a method of steroid-dependent disease treatment based on HSD3B1. Nima Sharifi is a co-inventor on this patent application